Novo Nordisk A/S Common Stock · Stock-Based Compensation

Latest reportedkr 0.00 DKKperiod endingJun 30, 2026

NVO Stock-Based Comp · DKK (kr 0.00 → kr 0.00)

Annual stock-based compensation

High-resolution chart · PNG

NVO stock-based compensation history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Stock-Based Compensation — Annual fiscal periods (DKK)
Period ending	Stock-Based Compensation (DKK)
Dec 31, 2025	0
Dec 31, 2024	2,289,000,000
Dec 31, 2023	2,149,000,000
Dec 31, 2022	1,539,000,000
Dec 31, 2021	1,040,000,000
Dec 31, 2020	823,000,000
Dec 31, 2019	363,000,000
Dec 31, 2018	414,000,000
Dec 31, 2017	292,000,000
Dec 31, 2016	368,000,000
Dec 31, 2015	442,000,000
Dec 31, 2014	371,000,000
Dec 31, 2013	409,000,000
Dec 31, 2012	308,000,000
Dec 31, 2011	0
Dec 31, 2010	0
Dec 31, 2009	0
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0